Open AccessADEQUATE ANTITHROMBOTIC THERAPY: REDUCTION OF MORTALITY BY THE RESULTS OF INTERNATIONAL CLINICAL TRIALS (literature review)
Author(s) -
D. P. Salivonchyk
Publication year - 2013
Publication title -
problemy zdorovʹâ i èkologii
Language(s) - English
Resource type - Journals
eISSN - 2708-6011
pISSN - 2220-0967
DOI - 10.51523/2708-6011.2013-10-1-4
Subject(s) - antithrombotic , medicine , clopidogrel , percutaneous coronary intervention , medical prescription , intensive care medicine , acute coronary syndrome , clinical trial , cardiology , surgery , aspirin , myocardial infarction , pharmacology
The article considers adequate antithrombotic therapy in acute coronary syndromes, which on the basis of evidence-based medicine makes it possible to significantly reduce mortality in patients. At the present stage, the application of clopidogrel requires its earliest prescription to the patients during their first visit to the doctor with the account of forthcoming percutaneous coronary surgery.